166 related articles for article (PubMed ID: 34863820)
1. Type-III interferon stimulated gene TRIM31 mutation in an HBV patient blocks its ability in promoting HBx degradation.
Xu F; Song H; Xiao Q; Wei Q; Pang X; Gao Y; Tan G
Virus Res; 2022 Jan; 308():198650. PubMed ID: 34863820
[TBL] [Abstract][Full Text] [Related]
2. Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation.
Tan G; Yi Z; Song H; Xu F; Li F; Aliyari R; Zhang H; Du P; Ding Y; Niu J; Wang X; Su L; Qin FX; Cheng G
Cell Rep; 2019 Dec; 29(11):3551-3563.e3. PubMed ID: 31825835
[TBL] [Abstract][Full Text] [Related]
3. TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg-positive chronic hepatitis B Patients.
Luo M; Hou J; Mai H; Chen J; Chen H; Zhou B; Hou J; Jiang DK
Aliment Pharmacol Ther; 2022 Sep; 56(5):878-889. PubMed ID: 35872575
[TBL] [Abstract][Full Text] [Related]
4. Type III interferon-induced CBFβ inhibits HBV replication by hijacking HBx.
Xu F; Song H; Xiao Q; Li N; Zhang H; Cheng G; Tan G
Cell Mol Immunol; 2019 Apr; 16(4):357-366. PubMed ID: 29523836
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
[TBL] [Abstract][Full Text] [Related]
6. SIAH2 suppresses c-JUN pathway by promoting the polyubiquitination and degradation of HBx in hepatocellular carcinoma.
Hu Q; Liu Z; Liu Y; Qiu J; Zhang X; Sun J; Zhang B; Shi H
J Cell Mol Med; 2024 Jun; 28(11):e18484. PubMed ID: 38842124
[TBL] [Abstract][Full Text] [Related]
7. HERC5 E3 ligase mediates ISGylation of hepatitis B virus X protein to promote viral replication.
Bawono RG; Abe T; Qu M; Kuroki D; Deng L; Matsui C; Ryo A; Suzuki T; Matsuura Y; Sugiyama M; Mizokami M; Shimotohno K; Shoji I
J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34661519
[TBL] [Abstract][Full Text] [Related]
8. Proteasomal activator 28 gamma stabilizes hepatitis B virus X protein by competitively inhibiting the Siah-1-mediated proteasomal degradation.
Han J; Kim H; Jeong H; Yoon H; Jang KL
Biochem Biophys Res Commun; 2021 Nov; 578():97-103. PubMed ID: 34555669
[TBL] [Abstract][Full Text] [Related]
9. Tumor Suppressor p53 Inhibits Hepatitis B Virus Replication by Downregulating HBx via E6AP-Mediated Proteasomal Degradation in Human Hepatocellular Carcinoma Cell Lines.
Lim HY; Han J; Yoon H; Jang KL
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298868
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
[TBL] [Abstract][Full Text] [Related]
11. The impact of HBx protein on mitochondrial dynamics and associated signaling pathways strongly depends on the hepatitis B virus genotype.
Schollmeier A; Basic M; Glitscher M; Hildt E
J Virol; 2024 May; 98(5):e0042424. PubMed ID: 38629837
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication.
Murphy CM; Xu Y; Li F; Nio K; Reszka-Blanco N; Li X; Wu Y; Yu Y; Xiong Y; Su L
Cell Rep; 2016 Sep; 16(11):2846-2854. PubMed ID: 27626656
[TBL] [Abstract][Full Text] [Related]
13. E3 ubiquitin ligase TRIM21 restricts hepatitis B virus replication by targeting HBx for proteasomal degradation.
Song Y; Li M; Wang Y; Zhang H; Wei L; Xu W
Antiviral Res; 2021 Aug; 192():105107. PubMed ID: 34097931
[TBL] [Abstract][Full Text] [Related]
14. DDB1 Stimulates Viral Transcription of Hepatitis B Virus via HBx-Independent Mechanisms.
Kim W; Lee S; Son Y; Ko C; Ryu WS
J Virol; 2016 Nov; 90(21):9644-9653. PubMed ID: 27535046
[TBL] [Abstract][Full Text] [Related]
15. PreS1BP mediates inhibition of Hepatitis B virus replication by promoting HBx protein degradation.
Wang J; Yuan X; Wang Y; Zhang Y; Han M; Lu H; Liu S; Zhang Y; Ge F; Liu Y; Cheng J
Virus Res; 2024 Mar; 341():199326. PubMed ID: 38253259
[TBL] [Abstract][Full Text] [Related]
16. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.
Sartorius K; An P; Winkler C; Chuturgoon A; Li X; Makarova J; Kramvis A
Front Immunol; 2021; 12():661204. PubMed ID: 33995383
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.
Li W; Chen G; Yu X; Shi Y; Peng M; Wei J
Int J Clin Exp Pathol; 2013; 6(6):1076-85. PubMed ID: 23696925
[TBL] [Abstract][Full Text] [Related]
18. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.
Ali A; Abdel-Hafiz H; Suhail M; Al-Mars A; Zakaria MK; Fatima K; Ahmad S; Azhar E; Chaudhary A; Qadri I
World J Gastroenterol; 2014 Aug; 20(30):10238-48. PubMed ID: 25132741
[TBL] [Abstract][Full Text] [Related]
20. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
